Desmopressin oral melt    (DrugBank: Desmopressin)

1 disease
IDDisease name (Link within this page)Number of trials
72Pituitary ADH secretion disorder1

72. Pituitary ADH secretion disorder    [ 36 clinical trials,   22 drugs,   (DrugBank: 5 drugs),   2 drug target genes,   4 drug target pathways]
Searched query = "Pituitary ADH secretion disorder", "Inappropriate antidiuretic hormone secretion", "Syndrome of inappropriate secretion of antidiuretic hormone", "Inappropriate ADH syndrome", "Syndrome of inappropriate ADH", "Central diabetes insipidus", "Syndrome of inappropriate secretion of ADH", "SIADH"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 36 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01280188
(ClinicalTrials.gov)
January 201119/1/2011A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).Peroral Administration of Different Doses of Desmopressin Administered as a New Orally-Disintegrating Tablet and Desmopressin for Nasal Administration in the Treatment of CDI in Japanese PatientsCentral Diabetes InsipidusDrug: Desmopressin Oral Melt;Drug: Desmopressin intranasalFerring PharmaceuticalsNULLCompleted6 Years75 YearsBoth20Phase 3Japan